Europe Diltiazem Market Growth and Forecast by 2028
Europe Diltiazem Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Capsules, Injection, and Tablets) and Application (Angina, Hypertension, and Others)
- Report Date : Oct 2021
- Report Code : TIPRE00025366
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 126
The Europe diltiazem market is expected to reach US$ 207.38 million by 2028 from US$ 95.08 million in 2021; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028.
Rise in government initiatives for promotion, increase in the prevalence of cardiovascular diseases, and rise in the elderly population with heart diseases worldwide are expected to boost the market growth over the years. However, side effects of diltiazem on consumption are likely to negatively impact the growth of the market in the coming years.
Heart diseases are primarily observed in older adults due to their weak immunity and other major health problems. According to the Global Ageing 2019 survey, the world's population of 65 and above totaled 703 million in 2019. The elderly demographic is expected to double to 1.5 billion people by 2050. This demographic is more susceptible to Cardiovascular dieseses (CVDs) such as arrhythmias. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. Structural and functional changes in the cardiovascular system associated with aging are major causes of cardiovascular diseases. Therefore, the rising geriatric population worldwide is leading to an increase in the incidence of cardiovascular disease, bolstering the growth of the diltiazem market. Also, the diltiazem market is characterized by the presence of various small and big companies. The market players adopt new product launches, regional expansions, and product approvals to increase their market share. The players are investing in R&D to develop advanced technologies and gain significant revenue share in Europe. For instance, in March 2021, Glenmark Pharmaceuticals was granted competitive generic therapy (CGT) designation for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg; therefore, it is eligible for 180 days of CGT exclusivity upon commercial marketing. Thus, such recent developments are expected to act as a future trend in the diltiazem market
The European market is severely hit due to the exponential increase of COVID-19 cases in the region. The rising rate of COVID-19 is resulting in increased stress on the region's healthcare system, increasing the need for diagnostic tests in its healthcare system, encouraging the expansion of the sector in this region. Hypertension has been recorded in various cases and retrospective groups as a possible risk factor for the frequency and severity of COVID-19. Since the SARS-CoV-2's high infectivity rates, a possible interaction between COVID-19 and hypertension is worrisome. Diltiazem may be helpful to treat hypertension associated with COVID-19. Overall, diltiazem plays dual effects on hypertension-linked COVID-19 treatment by lowering high blood pressure and restraining NF-kb signaling pathway-related inflammation. The region witnessed some shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. Market players and end users lost their business due to the temporarily shutting down of industries in various regions. However, the diltiazem market witnessed growth during the pandemic as it is anticipated to inhibit viral growth and related hypertension.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE DILTIAZEM MARKET SEGMENTATION
By Product Type
- Tablet
- Capsules
- Injection
By Application
- Hypertension
- Angina
- Others
By Country
- Italy
- Germany
- Spain
- France
- UK
- Rest of Europe
Company Profiles
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd
- MYLAN N.V.
- Pfizer Inc.
- Sandoz (Novartis AG)
- Sun Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals PLC
- Zydus Cadila
- Glenmark
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Diltiazem Market – By Product Type
1.3.2 Europe Diltiazem Market – By Application
1.3.3 Europe Diltiazem Market – By Country
2. Europe Diltiazem Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Diltiazem Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe– PEST Analysis
4.3 Experts Opinion
5. Diltiazem Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Cardiovascular Disease Incidence
5.1.2 Increasing Elderly Population
5.2 Market Restraints
5.2.1 Side Effects of Diltiazem
5.3 Future Trends
5.3.1 Recent Developments in Market
5.4 Impact Analysis
6. Diltiazem Market – Europe Analysis
6.1 Europe Diltiazem Market Revenue Forecast and Analysis
7. Diltiazem Market Analysis and forecasts to 2028 – Product Type
7.1 Overview
7.2 Diltiazem Market Share by Product Type 2021 & 2028 (%)
7.3 Capsules
7.3.1 Overview
7.3.2 Capsules Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Injection
7.4.1 Overview
7.4.2 Injection Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Tablets
7.5.1 Overview
7.5.2 Tablet Market Revenue and Forecast to 2028 (US$ Mn)
8. Diltiazem Market Analysis and Forecasts To 2028 – Application
8.1 Overview
8.2 Diltiazem Market Share by Application 2021 & 2028 (%)
8.3 Angina
8.3.1 Overview
8.3.2 Angina Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Hypertension
8.4.1 Overview
8.4.2 Hypertension Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Others
8.5.1 Overview
8.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. Diltiazem Market – Europe Analysis
9.1 Europe: Diltiazem Market
9.1.1 Europe: Diltiazem Market, by Country, 2021 & 2028 (%)
9.1.1.1 UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 UK: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 UK: Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
9.1.1.2 Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Germany: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 Germany: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.3 France: Diltiazem Market - Revenue and Forecasts to 2028 (USD Million)
9.1.1.3.1 France: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 France: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 France: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.4 Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Spain: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.3 Spain: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.5 Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Italy: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
9.1.1.5.3 Italy: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.6 Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.3 Rest of Europe: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Diltiazem Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Diltiazem Market–Industry Landscape
11.1 Overview
11.2 Recent Growth Strategies In The Diltiazem Market
12. Company Profiles
12.1 Bausch Health Companies Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Teva Pharmaceutical Industries Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MYLAN N.V.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Sandoz (Novartis AG)
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sun Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Hikma Pharmaceuticals PLC
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Zydus Cadila
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Glenmark
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. UK Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 2. UK Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. Germany Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 4. Germany Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 5. France Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 6. France Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 7. Spain Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Spain Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Italy Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Italy Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of Europe Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of Europe Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Glossary of Terms, Diltiazem Market
LIST OF FIGURES
Figure 1. Diltiazem Market Segmentation
Figure 2. Diltiazem Market Segmentation, By Country
Figure 3. Europe Diltiazem Market Overview
Figure 4. Tablets Held the Largest Share of the Product Segment in Diltiazem Market
Figure 5. Europe Diltiazem Market – Leading Country Markets (US$ Million)
Figure 6. Europe and PEST Analysis
Figure 7. Diltiazem Market: Impact Analysis of Drivers and Restraints
Figure 8. Europe Diltiazem Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Diltiazem Market Share by Product Type 2021 & 2028 (%)
Figure 10. Capsules Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Injection Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Tablet Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Diltiazem Market Share by Application 2021 & 2028 (%)
Figure 14. Angina Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Hypertension Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe: Diltiazem Market, by Key Country – Revenue (2021) (USD Million)
Figure 18. Europe: Diltiazem Market, by Country, 2021 & 2028 (%)
Figure 19. UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 20. Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 21. France: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 22. Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 23. Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Impact of COVID-19 Pandemic in European Country Markets
- Bausch Health Companies Inc.
- Teva Pharmaceutical Industries Ltd
- MYLAN N.V.
- Pfizer Inc.
- Sandoz (Novartis AG)
- Sun Pharmaceutical Industries Ltd
- Hikma Pharmaceuticals PLC
- Zydus Cadila
- Glenmark
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Oct 2021
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Oct 2021
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Oct 2021
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Oct 2021
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Oct 2021
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Oct 2021
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Get Free Sample For